» Articles » PMID: 11790555

The P53 and Mdm2 Families in Cancer

Overview
Publisher Elsevier
Specialties Biology
Genetics
Date 2002 Jan 16
PMID 11790555
Citations 69
Authors
Affiliations
Soon will be listed here.
Abstract

Cells within an organism are occasionally exposed to either intracellular or environmental stress. Such stress often has genotoxic potential that enhances the probability of cancer. Two gene families, the p53 family (p53, p63 and p73) and the Mdm2 family (Mdm2 and MdmX), serve as major integrators of the signals generated by genotoxic and oncogenic stress. Their co-ordinated modulation ensures an optimal response to stress and decreases the likelihood of cancer. Work over the past year has provided better understanding of the p53-Mdm2 module that lies in the heart of this regulatory network, and of the intricate interplay between the various members of the network.

Citing Articles

p53 Genetics and Biology in Lung Carcinomas: Insights, Implications and Clinical Applications.

Benitez D, Cumplido-Laso G, Olivera-Gomez M, Del Valle-Del Pino N, Diaz-Pizarro A, Mulero-Navarro S Biomedicines. 2024; 12(7).

PMID: 39062026 PMC: 11274425. DOI: 10.3390/biomedicines12071453.


Meta-Analysis of 49 SNPs Covering 25,446 Cases and 41,106 Controls Identifies Polymorphisms in Hormone Regulation and DNA Repair Genes Associated with Increased Endometrial Cancer Risk.

Das A, Chaudhary N, Tyagi S, Agarwal S Genes (Basel). 2023; 14(3).

PMID: 36981012 PMC: 10048726. DOI: 10.3390/genes14030741.


In Vitro Toxicity Evaluation of Cyanotoxins Cylindrospermopsin and Microcystin-LR on Human Kidney HEK293 Cells.

Diez-Quijada L, Puerto M, Gutierrez-Praena D, Turkina M, Campos A, Vasconcelos V Toxins (Basel). 2022; 14(7).

PMID: 35878167 PMC: 9316492. DOI: 10.3390/toxins14070429.


Application of In Silico Filtering and Isothermal Titration Calorimetry for the Discovery of Small Molecule Inhibitors of MDM2.

Alali H, Bloch I, Rapaport I, Rodrigues L, Sher I, Ansbacher T Pharmaceuticals (Basel). 2022; 15(6).

PMID: 35745671 PMC: 9230431. DOI: 10.3390/ph15060752.


The Role of p53 Expression in Patients with RAS/BRAF Wild-Type Metastatic Colorectal Cancer Receiving Irinotecan and Cetuximab as Later Line Treatment.

Ziranu P, Lai E, Schirripa M, Puzzoni M, Persano M, Pretta A Target Oncol. 2021; 16(4):517-527.

PMID: 33970400 PMC: 8266772. DOI: 10.1007/s11523-021-00816-3.